Satsuma Pharmaceuticals, Inc. Proceeds from Issuance Initial Public Offering
Satsuma Pharmaceuticals, Inc. reported Proceeds from Issuance Initial Public Offering of $81.44 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2021-03-25
- Satsuma Pharmaceuticals, Inc. proceeds from issuance initial public offering for the quarter ending 2019-12-31 was $6.53M.
- Satsuma Pharmaceuticals, Inc. proceeds from issuance initial public offering for fiscal 2019 was $81.44M.
| Period end | Proceeds from Issuance Initial Public Offering | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|
| 2019-12-31 | $6.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $81.44M 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $74.90M 10-Q · filed 2020-11-10 | |||
| 2019-09-17 | $82.50M 10-K · filed 2021-03-25 |